ArticlePharmaceuticals (Basel, Switzerland)2026
Exploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking.
Mingli Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.